Company profile:
Renfu Pharmaceutical Group Co., Ltd. was established on 1993-03-30 with a registered capital of1353,704,302,000 yuan. The legal representative is Wang, the company address is No.666, Avenue, Donghu High-tech Zone, Wuhan, and the unified social credit code and tax number are 9 1420 1003006544. Biotechnology research and development; R&D and sales of chemical products (except hazardous chemicals); Technology development, technology transfer and technical services; Import and export of goods, technologies and agents (except those prohibited or restricted by the state); Investment in pharmaceutical industry and medical institutions; Management of pharmaceutical industry and medical institutions; Real estate development, commercial housing sales (qualification level 3); Organize the "three to one supplement" business. (Projects that are subject to examination and approval according to law shall be examined and approved by relevant departments before business activities can be carried out). The industrial and commercial registration number of Renfu Pharmaceutical Group Co., Ltd. is 4201000011675.
Branch:
Foreign investment:
Wuhan Renfu Health Care Industry Co., Ltd., the legal representative is Chen Yuguo, the date of investment is April 8, 2009, the enterprise status is opening, the registered capital is 2000.0000000, and the investment ratio is 5 1.00%.
Zhiying Xincheng (Wuhan) Equity Investment Management Co., Ltd., the legal representative is Li Qianlun, the date of contribution is 20 16-0 1-25, the enterprise status is in operation (opening), the registered capital is 1000.000000, and the contribution ratio is 49.00%.
Xinjiang Uyghur Medicine Co., Ltd., the legal representative is Yin Qiang, the date of investment is 200 1-03-26, the enterprise status is in operation (opening), the registered capital is 2000.0000000, and the contribution ratio is 73.25%.
Yichang Maternal and Child Hospital Management Co., Ltd., the legal representative is Liu Lei, the date of investment is 20 16-05- 19, the enterprise status is in operation (opening), the registered capital is 52,967.530,000 yuan, and the contribution ratio is 66.00%.
Sichuan Renfu Pharmaceutical Co., Ltd., legal representative Tian Ping, was established by investment on September 20, 2005. The enterprise is in business, with a registered capital of 10900.000000, and a contribution ratio of 70.00%.
Wuhan Renfu Medical Optoelectronic Co., Ltd., the legal representative is Xu Jiansheng, the date of contribution is 1998-07-30, the enterprise status is in operation (opening), the registered capital is 500.00000000, and the contribution ratio is 70.00%.
Wuhan Fuke New Drug Co., Ltd., with legal representative Jie Shen, was invested on August 3, 2007, and the enterprise status was in business, with registered capital of/kloc-0 1000.000000, and the investment ratio was 65.00%.
Hubei Renfu Chengtian Pharmaceutical Co., Ltd., the legal representative is Liu, the date of investment is 20 13-03- 19, the enterprise status is business (opening), the registered capital is 8093.000000, and the investment ratio is 5 1.8 1%.
Hubei Mulan Tongda Technology Co., Ltd., the legal representative is Xia Mulan, the date of contribution is June 20, 2003, the enterprise status is business (opening), the registered capital is 2000.00000000, and the contribution ratio is 19.00%.
Hangzhou Foster Pharmaceutical Co., Ltd., legal representative Xu, the date of investment was 200 1-09-05, and the enterprise was in the state of opening, with a registered capital of 750.00000000 and a contribution ratio of 70.00%.
Yichang Three Gorges Pharmaceutical Co., Ltd., the legal representative is Yan Tao, the date of investment is 1999-07-20, the enterprise status is opening, the registered capital is 39,000.000000, and the investment ratio is 100.00%.
Wuhan Ruicheng Equity Investment Management Co., Ltd., the legal representative is Sun Jing, the date of investment is 20 15-05-28, the enterprise status is in operation (opening), the registered capital is 500.00000000, and the contribution ratio is 32.50%.
Wuhan Bowo Biotechnology Co., Ltd., the legal representative is Wu Ke, the date of investment is 2012-12-31,and the enterprise status is open, with a registered capital of 7,764,800 and a contribution ratio of 6.26%.
Beijing Barry Medical Equipment Co., Ltd., the legal representative is Wei Wei, the date of investment is 2000-0 1-06, and the enterprise status is in business, with the registered capital of 1000.000000, and the contribution ratio is 80.00%.
Guangzhou Bellon Environmental Protection Thermoelectric Equipment Co., Ltd., the legal representative is Sun Jianzheng, the date of investment is 1995- 10-24, and the enterprise status is opening, with a registered capital of 5580.000000 and a contribution ratio of 73.66%.
Wuhan Renfu Biomedical Industry Investment Fund Center (limited partnership), the legal representative is Wuhan Ruicheng Equity Investment Management Co., Ltd. (appointed representative: Li Qianlun), the date of investment is 2016-1-17, the enterprise status is in operation (opening), and the registered capital is 250.
Hubei Shanzhuo House Leasing Co., Ltd., the legal representative is Xia Yuan, the date of contribution is 2018-1-26, the enterprise status is in operation (opening), the registered capital is 1000.000000, and the contribution ratio is1000.
Hubei Radio and Television Sunshine Charity Culture Media Co., Ltd., legal representative Sun Tingjuan, date of contribution: 2007- 10-25, enterprise status cancelled, registered capital: 300.00000000, contribution ratio: 15.00%.
Yan Huang, the legal representative of Wuhan Xinchuang Venture Capital Co., Ltd., invested on 20 10-03- 12, and the enterprise status is in operation (opening), with a registered capital of 6000.000000 yuan and a contribution ratio of 27.50%.
TF Securities Co., Ltd., the legal representative of which is Lei Yu, was invested on March 29th, 2000, and the enterprise was in the state of opening, with a registered capital of 518000.0000000, with a contribution ratio of 2.88%.
Shareholders:
Social tradable shares, with a capital contribution ratio of 23.48% and subscribed capital contribution of 365,438+0.65 million.
The contribution ratio of Wuhan Contemporary Science and Technology Industry Group Co., Ltd. is 6. 12%, and the subscribed capital contribution is 8284.438+0000.
Huabao Trust Co., Ltd. contributed 65,438+0.48%, and the subscribed capital contribution was 2000,000 yuan.
Taikang Asset Management Co., Ltd. contributed 0.96%, and the subscribed capital contribution was 1300.000000.
The contribution ratio of China Chengxin Trust Co., Ltd. is 0.96%, and the subscribed capital contribution is 1300.000000.
Rongtong Fund Management Co., Ltd. contributed 0.74%, and the subscribed capital contribution was 1000.000000.
The contribution ratio of orient securities Co., Ltd. is 0.55%, and the subscribed capital contribution is 750 million yuan.
The contribution ratio of Wuhan Gaoxin State Holding Group Co., Ltd. is 0.55%, and the subscribed capital contribution is 738.5438+0 100.
Executives:
Li Jie is the director and general manager of our company.
Deng is a director of our company.
Du is a supervisor of the Company.
Zhou Hansheng is a director of the company.
Zhu Jianmin is in charge of this company.
He Hesheng is a director of this company.
Zhang Xiaodong is a director of the company.
Guy Song Mei is a supervisor in this company.
Wang is a director of this company.
Qi Min is in charge of this company.
Wang is the chairman of the company.
Xie Huobao is a director of the company.
Huang Feng is a director of this company.
He Hao is in charge of the company.